டேவிட் போரா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டேவிட் போரா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டேவிட் போரா Today - Breaking & Trending Today

Bicycle Therapeutics plc: Bicycle Therapeutics to Participate in Upcoming Virtual Investor Conferences


Bicycle Therapeutics plc: Bicycle Therapeutics to Participate in Upcoming Virtual Investor Conferences
Bicycle
) technology, today announced that management will participate in the following virtual investor conferences in June:
Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021; fireside chat at 11:00 a.m. ET
Goldman Sachs 42
nd Annual Global Healthcare Conference on Tuesday, June 8, 2021; fireside chat at 8:00 a.m. ET
The JMP Securities Life Sciences Conference on Thursday, June 17, 2021; fireside chat at 12:00 p.m. ET
A live webcast of the fireside chats will be accessible in the Investors Media section of Bicycle s website at www.bicycletherapeutics.com. Archived replays of the webcasts will be available for 30 days following the presentation dates. ....

United Kingdom , David Borah , Mary Jane Elliott , Goldman Sachs , Consilium Strategic Communications , Securities Life Sciences Conference On , Bicycle Therapeutics , Virtual Healthcare Conference , Annual Global Healthcare Conference , Life Sciences Conference , Investors Media , Bicycle Toxin Conjugate , Drug Development , Cancer Research United , Capital Markets Investor Relations , Strategic Communications , ஒன்றுபட்டது கிஂக்டம் , டேவிட் போரா , மேரி ஜேன் எலியட் , கோல்ட்மேன் சாக்ஸ் , கொன்சில்ிும் மூலோபாய தகவல்தொடர்புகள் , மிதிவண்டி சிகிச்சை , மெய்நிகர் சுகாதாரம் மாநாடு , ஆண்டு உலகளாவிய சுகாதாரம் மாநாடு , வாழ்க்கை அறிவியல் மாநாடு , முதலீட்டாளர்கள் மீடியா ,

Bicycle Therapeutics plc: Bicycle Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update


Bicycle Therapeutics plc: Bicycle Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
BT7480, the lead Bicycle
tumor-targeted immune cell agonist, presented at AACR Annual Meeting 2021 New Drugs on the Horizon session; remains on-track for 2H 21 clinical trial start
Achieved significant recent progress across pipeline of Bicycle
-based therapies beyond oncology
Raised $75.0 million through at-the-market offering program; cash of $195.9 million as of March 31, 2021 expected to provide financial runway through multiple clinical milestones and into 2024
Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (
Bicycle) technology, today reported financial results for the first quarter ended March 31, 2021 and discussed recent corporate updates. ....

United States , United Kingdom , David Borah , Jose Carlos Gutierrez Ramos , Mary Jane Elliott , Kevin Lee , Dementia Discovery Fund , Exchange Commission , American Association For Cancer Research , University Of Warwick , Hercules Capital Inc , Consilium Strategic Communications , Bicycle Toxin Conjugates , Chief Executive Officer , American Association , Cancer Research , Annual Meeting , Innovate United Kingdom , Biomedical Catalyst , Penicillin Binding Protein , Scientific Advisory Board , Balance Sheet , Hercules Capital , Bicycle Toxin Conjugate , Drug Development , Cancer Research United ,